A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
Key Details
- 1Researchers developed a deep learning model (SurvFinder) trained on whole slide histopathology images from stage II colorectal cancer patients.
- 2The study retrospectively analyzed multi-center data from patients in China and the United States.
- 3The AI model identified features associated with risk of recurrence at a higher success rate than traditional clinical prognostic tools.
- 4Study details and results are published in PLOS Medicine, open access.
Why It Matters
Digital pathology AI models can enhance prognostic accuracy and help personalize treatment plans for cancer patients. Outperforming current clinical tools could enable better risk stratification and improved outcomes in stage II colorectal cancer.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.